Claims for Patent: 10,065,007

Summary for Patent: 10,065,007

Title:	Breathing apparatus and method for support ventilation
Abstract:	In a method and breathing apparatus for providing support ventilation to a spontaneously breathing patient a pressure and/or a flow is monitored based on pressure and/or flow measurements, and efforts to inhale or exhale by the patient are detected based on changes in the monitored pressure and/or flow. When a change in the monitored pressure and/or flow indicating an effort to inhale or exhale is detected, the rate of that change is determined and used to calculate a suitable rate of change of pressure applied to the airways of the patient. By changing the applied pressure in accordance with the so determined suitable rate of change, the pressure rise time during inspiration and/or the pressure fall time during expiration can be adjusted to the needs of the patient to ensure efficient and comfortable ventilation.
Inventor(s):	Carl-Erik Troili, Mia Sköld
Assignee:	Maquet Critical Care AB
Application Number:	US14/005,923

Details for Patent 10,065,007

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	September 25, 2009		2031-03-18
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	December 30, 2009		2031-03-18
Merck Sharp & Dohme Llc	ZINPLAVA	bezlotoxumab	Injection	761046	October 21, 2016		2031-03-18

International Patent Family for US Patent 10,065,007

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2012128674
United States of America	2014116439
European Patent Office	2686050